| Year |
Citation |
Score |
| 2020 |
Butkovich LM, Houser MC, Chalermpalanupap T, Porter-Stransky KA, Iannitelli AF, Boles JS, Lloyd GM, Coomes AS, Eidson LN, De Sousa Rodrigues ME, Oliver DL, Kelly SD, Chang J, Bengoa-Vergniory N, Wade-Martins R, et al. Transgenic mice expressing human alpha-synuclein in noradrenergic neurons develop locus coeruleus pathology and non-motor features of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32868457 DOI: 10.1523/JNEUROSCI.1468-19.2020 |
0.52 |
|
| 2019 |
Kline EM, Butkovich LM, Bradner JM, Chang J, Gelbard H, Goodfellow V, Caudle WM, Tansey MG. The second generation mixed-lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss. Experimental Neurology. PMID 31077715 DOI: 10.1016/j.expneurol.2019.05.002 |
0.52 |
|
| 2019 |
Whyte AJ, Kietzman HW, Swanson AM, Butkovich LM, Barbee BR, Bassell GJ, Gross C, Gourley SL. Reward-related expectations trigger dendritic spine plasticity in the mouse ventrolateral orbitofrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30940719 DOI: 10.1523/JNEUROSCI.2031-18.2019 |
0.72 |
|
| 2018 |
Butkovich LM, Houser MC, Tansey MG. α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis. Frontiers in Neuroscience. 12: 626. PMID 30258347 DOI: 10.3389/fnins.2018.00626 |
0.52 |
|
| 2017 |
Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, Chang J, Grigoryan N, Factor SA, West AB, Boss JM, Tansey MG. LRRK2 levels in immune cells are increased in Parkinson's disease. Npj Parkinson's Disease. 3: 11. PMID 28649611 DOI: 10.1038/s41531-017-0010-8 |
0.52 |
|
| 2015 |
Butkovich LM, DePoy LM, Allen AG, Shapiro LP, Swanson AM, Gourley SL. Adolescent-onset GABAA α1 silencing regulates reward-related decision making. The European Journal of Neuroscience. PMID 26096050 DOI: 10.1111/ejn.12995 |
0.48 |
|
| Show low-probability matches. |